Skip to content
PAD
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
PAD
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
The Latest:
Jul 2
3-Year DETOUR2 Results Demonstrate Sustained Symptom Relief and Limb Preservation in Complex SFA Disease
See Release
All News
Archives
All
2026
2025
2024
2023
2022
2021
Mar 14
Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit
Mar 5
Endologix Appoints Mike Mathias as Chief Commercial Officer
Feb 29
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
Jan 25
Endologix Announces that Art Taylor Joins Board of Directors
Jan 9
Endologix Announces that Scott Ward Joins Board of Directors
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
